Jim Simons’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Jim Simons’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-192,100	Closed	-$30K	–	3663
2016 Q3	$30K	Sell	192,100 -3,000	-2%	-$693	﹤0.01%	3279
2016 Q2	$60K	Sell	195,100 -5,400	-3%	-$1.5K	﹤0.01%	3224
2016 Q1	$36K	Buy	200,500 +173,900	+654%	+$48.3K	﹤0.01%	3302
2015 Q4	$46K	Buy	+26,600	New	+$46.9K	﹤0.01%	3179

Other funds holding TLOG

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BWA

Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

Jim Simons's TLOG Position: Q4 2016 in Review

Jim Simons sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 192,100 shares — an estimated $30K sold.

Jim Simons first reported a position in TLOG in Q4 2015 and held it in 4 quarters. The position peaked at $60K in Q2 2016. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

Jim Simons reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
Jim Simons sold 192,100 TetraLogic Pharmaceuticals Corporation shares in Q4 2016, an estimated $30K.
Jim Simons first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2015 and held it in 4 quarters.
Jim Simons's TetraLogic Pharmaceuticals Corporation position peaked at $60K in Q2 2016.
3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.